Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07689682
Recruiting
OPM- MEG in Non-immune And iMmune-medIated Neurological Disease
Not applicable · United Kingdom · 2 sites
Registry update: 22 Oct 2026
NCT07599670
Recruiting
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
Phase 1/2 · China, United States · 13 sites
Registry update: 18 Sept 2026
NCT07512362
Recruiting
Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
Phase 2 · United States · 1 site
Registry update: 28 May 2026
NCT07614386
Recruiting
Radial Access Data in Vascular Interventions Registry
Not applicable · 1 site
Registry update: 23 Jun 2026
NCT07382726
Recruiting
Phase 1 Study Of Izalontamab Brengitecan + Adagrasib In NSCLC - The IZA-A Trial
Phase 1 · United States · 1 site
Registry update: 11 Aug 2026
NCT07324772
Recruiting
PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
Not applicable · United States · 1 site
Registry update: 24 Aug 2026
NCT07607119
Recruiting
PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer
Not applicable · South Korea · 1 site
Registry update: 28 May 2026
NCT07608588
Recruiting
Recovery From Post-Stroke Aphasia With rTMS Targeting Left or Right Anterior Temporal Lobe
Not applicable · United States · 1 site
Registry update: 29 May 2026
NCT07518147
Recruiting
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
Phase 3 · China · 1 site
Registry update: 2 Nov 2026
NCT06587165
Recruiting
Quantifying New Heart Muscle Cells
Not applicable · United States · 4 sites
Registry update: 15 Jun 2026
NCT07631767
Recruiting
Shift Workers' Health Behavior Action Program Across Europe
Not applicable · Germany, Netherlands, Poland · 5 sites
Registry update: 20 Aug 2026
NCT07225543
Recruiting
2-HOBA in Systemic Lupus Erythematosus
Phase 2 · United States · 1 site
Registry update: 22 May 2026
NCT07465913
Recruiting
Rocklatan vs Latanoprost Post-DSLT
Phase 4 · United States · 1 site
Registry update: 22 May 2026
NCT07571200
Recruiting
A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Phase 1 · Belgium, Canada, Germany, Spain, Netherlands · 11 sites
Registry update: 22 Sept 2026
NCT07493668
Recruiting
Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy
Phase 2 · South Korea · 1 site
Registry update: 22 May 2026
NCT07558538
Recruiting
A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
Early phase 1 · China · 1 site
Registry update: 11 Jun 2026
NCT07392892
Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Phase 2/3 · Canada, China, Spain, France, Israel, Italy, Japan, Puerto Rico, Taiwan, United States · 99 sites
Registry update: 13 Oct 2026
NCT07339059
Recruiting
Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Phase 2 · United States · 1 site
Registry update: 28 Jul 2026
NCT07572383
Recruiting
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Phase 2 · United States · 1 site
Registry update: 14 Jul 2026
NCT07239115
Recruiting
Levetiracetam for Seizure Prevention After Brain Tumor Surgery
Phase 3 · China · 1 site
Registry update: 28 May 2026

Ordered by registry start date. Freshness and sponsorship never change the order.